Ad is loading...
CMPX
Price
$1.49
Change
+$0.11 (+7.97%)
Updated
Nov 22 closing price
116 days until earnings call
TRVI
Price
$2.91
Change
+$0.18 (+6.59%)
Updated
Nov 22 closing price
116 days until earnings call
Ad is loading...

CMPX vs TRVI

Header iconCMPX vs TRVI Comparison
Open Charts CMPX vs TRVIBanner chart's image
Compass Therapeutics
Price$1.49
Change+$0.11 (+7.97%)
Volume$540.04K
CapitalizationN/A
Trevi Therapeutics
Price$2.91
Change+$0.18 (+6.59%)
Volume$1.76M
CapitalizationN/A
CMPX vs TRVI Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CMPX vs. TRVI commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and TRVI is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (CMPX: $1.49 vs. TRVI: $2.91)
Brand notoriety: CMPX and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 108% vs. TRVI: 321%
Market capitalization -- CMPX: $205.01M vs. TRVI: $223.68M
CMPX [@Biotechnology] is valued at $205.01M. TRVI’s [@Biotechnology] market capitalization is $223.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 4 bullish, 6 bearish.
  • TRVI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TRVI is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а +7.97% price change this week, while TRVI (@Biotechnology) price change was +5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

CMPX is expected to report earnings on Mar 19, 2025.

TRVI is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($224M) has a higher market cap than CMPX($205M). TRVI YTD gains are higher at: 117.164 vs. CMPX (-4.487). TRVI has higher annual earnings (EBITDA): -44.19M vs. CMPX (-53.58M). CMPX has more cash in the bank: 135M vs. TRVI (65.5M). TRVI has less debt than CMPX: TRVI (1.11M) vs CMPX (6.88M). CMPX has higher revenues than TRVI: CMPX (850K) vs TRVI (0).
CMPXTRVICMPX / TRVI
Capitalization205M224M92%
EBITDA-53.58M-44.19M121%
Gain YTD-4.487117.164-4%
P/E RatioN/AN/A-
Revenue850K0-
Total Cash135M65.5M206%
Total Debt6.88M1.11M618%
TECHNICAL ANALYSIS
Technical Analysis
CMPXTRVI
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICSSX18.230.31
+1.73%
VY® Columbia Small Cap Value II S
NIOAX13.500.14
+1.05%
Neuberger Berman Intl Small Cap A
FDFIX25.520.09
+0.35%
Fidelity Flex 500 Index
FMUIX14.980.04
+0.27%
Federated Hermes Muni and Stock Adv IS
NBSMX54.10N/A
N/A
Neuberger Berman Small Cap Growth Instl

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with FHTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+7.97%
FHTX - CMPX
40%
Loosely correlated
+1.55%
ABCL - CMPX
40%
Loosely correlated
+1.47%
XNCR - CMPX
38%
Loosely correlated
+3.78%
AURA - CMPX
37%
Loosely correlated
-0.89%
ABOS - CMPX
37%
Loosely correlated
+2.60%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with SCPH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then SCPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+6.59%
SCPH - TRVI
37%
Loosely correlated
-3.18%
GBIO - TRVI
37%
Loosely correlated
+3.79%
AURA - TRVI
36%
Loosely correlated
-0.89%
CMPX - TRVI
36%
Loosely correlated
+7.97%
EDIT - TRVI
36%
Loosely correlated
+2.95%
More